(Q42497911)

1 November 2017

title

In vitro endothelial cell activation and inflammatory responses in end-stage heart failure (English)

1 reference

1 November 2017

0 references

0 references

0 references

Ginette S Hoare

1

1 reference

1 November 2017

Emma J Birks

2

1 reference

1 November 2017

Christopher Bowles

3

1 reference

1 November 2017

Nandor Marczin

4

1 reference

1 November 2017

Magdi H Yacoub

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

6 July 2006

1 reference

Journal of Applied Physiology

1 November 2017

published in

1 reference

1 November 2017

volume

101

1 reference

1 November 2017

issue

5

1 reference

1 November 2017

page(s)

1466-1473

1 reference

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Endothelial cell activation in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Chromatin modification and the endothelial-specific activation of the E-selectin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Inotropes inhibit endothelial cell surface adhesion molecules induced by interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

The role of tumor necrosis factor alpha blockade in the treatment of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Chemokine expression in endothelial cells and monocytes is differentially regulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Two waves of nuclear factor kappaB recruitment to target promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

Activation of NF-κB via the IκB Kinase Complex Is Both Essential and Sufficient for Proinflammatory Gene Expression in Primary Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01497.2005

10.1152/JAPPLPHYSIOL.01497.2005

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference